ArticleVirology journal2026
HIV-1 and HIV-2 interaction results in reduced cell infectivity and viral replication in vitro.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring dual infection, HIV-1 and HIV-2 may infect the same cell, either simultaneously or sequentially. When these closely related lentiviruses co-infect, HIV-2 has been found to inhibit HIV-1 replication in vitro. In-patient infection data suggests that dual infection attenuates disease progression. Mechanisms underlying this inhibition have not been fully elucidated. Here, we assessed HIV-1 infectivity in presence or absence of HIV-2 in cell culture.
methodsHIV-1 subtypes A, B, C, and CRF02_AG were used to infect TZM-bl reporter cells as single infections or as dual infections with HIV-2. Infectious titer concentrations were determined by cytopathic effect-based method (TCID50) and P24 ELISA was used to determine p24 concentration in supernatant. Infectivity was determined using luminescence assay, while qPCR was used to determine expression of cell-associated unspliced and multiply spliced HIV-1 RNA. HIV-1 cell free viral RNA (vRNA) levels were quantified in cell supernatants.
resultsDual infections (simultaneous and sequential) resulted in reduced HIV-1 infectivity and replication relative to single infections. The reduction in infectivity varied among HIV-1 subtypes. Additionally, evaluation of expression levels of unspliced (us) and multiply spliced (ms) HIV-1 RNAs revealed lower expression of these RNA species in simultaneous dual infections for all the four subtypes tested. The same trend was observed for sequential dual infection with the exception of subtype B, which showed a slight increase in levels of usRNA. In both simultaneous and sequential dual infections, expression of msRNA was lower relative to HIV-1 mono-infection. Again, subtype B maintained the same trend as observed in usRNA during sequential dual infection. Despite the observed subtype specific variations, lower HIV-1 infectivity in dual infections coincided with reduced HIV-1 viral loads.
conclusionIn summary, this study demonstrates a significant reduction in HIV-1 infectivity in the presence of HIV-2. Reduced infectivity was characterized by lower viral loads and coincided with reduced HIV-1 transcription and splicing. These findings pave way for future mechanistic studies to understand the drivers of reduced infectivity in dual infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.